Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.660
+0.040 (2.47%)
At close: Oct 8, 2025, 4:00 PM EDT
1.680
+0.020 (1.20%)
After-hours: Oct 8, 2025, 7:32 PM EDT
Inhibikase Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.